For tidlig fødte har økt risiko for #KOLS og #astma, viser studier fra Norge @ntnuhelse og Finland @OYS_sairaala @THLorg

We have a vacancy for a PhD candidate who will be part of designing and running a clinical trial on #PrecisionMedicine, where we make use of #ColonCancer lab cultivated cells for therapy selection @NTNUikom @asmundflobak @Kreftforeningen

RT @asmundflobak: Are you interested in a PhD position on functional preicision medicine for colon cancer? See our PhD application: https…

Førsteamanuensis Michael Due Larsen, universitetslektor Espen S. Kolberg og kolleger lanserte denne uka læreboken «Kasuistikker i klinisk farmasi», en lærebok som beskriver den kliniske farmasøytens rolle i det tverrfaglige teamet rundt pasienten. Vi gratulerer med utgivelsen!

RT @Spiomet4Health: Acne, irregular periods, high amount of body hair, does it sound familiar? If you have polycystic ovary syndrome (#PCOS…

In Norway, the burden of invasive group B streptococcal infection during infancy is considerable and continues to affect children well beyond infancy. @Marenmi2

RT @trudeflo: Exciting opportunity to conduct cutting-edge research in Tuberculosis drug discovery in an Academia-Industry collaboration le…

RT @asmundflobak: One day conference on 'a healthy future' from NTNU Health - I'm looking forward to the talks and…

RT @asmundflobak: Are you interested in joining our research group @NTNUikom in Trondheim, and work and work on tomorrow's biomarkers for c…

We have a vacancy for one PhD candidate in #bioinformatics at @NTNUikom within the field of computational precision medicine, and with a focus on multi-omics data integration for cancer signalling modelling @asmundflobak

RT @NathalieJuYa: We wrote a preview on the latest article by @LehtinenLab on choroid plexus targeted therapies against post-hemorrhagic hy…

RT @NathalieJuYa: Preprint alert! Cilia come in many different shapes and structures. #Cilia of olfactory sensory n…

RT @MagnusSteigedal: Two NTNU Discovery main projects to @NTNUikom researchers and inovators. Congratulations to Mirta Sousa and Lars Adde!…

We have a vacancy for a PhD candidate in #SpatialTranscriptomics @NTNUikom on the project Identifying small-cell lung cancer patients responding to immune checkpoint inhibitors #SmallCellLungCancer

Mødre som føder svært premature barn, har et sterkt behov for å få bekreftet at barnet er livskraftig. Det oppnås best gjennom tidlig hudkontakt. @NTNUikom @TSykepleien

RT @TorilHol: Finally, our story on #endoglin and #BMP9 signaling with the group of @wli225 is out. This is also the first 1st author paper…

Svært interessant sak i A-magasinet om hvordan @Magnarbjoras ved @NTNUikom gir Julian og barn som ham et håp:

We have vacancies for two PhD candidates in the AICAN group. The candidates will develop and validate machine learning techniques for automatic assessment of digital breast and lung cancer tissue sections. @NTNUikom @ingerid_r

The birth prevalence of dyskinetic CP in Norway was low and decreased significantly from 1996 to 2015. It suggests that general improvements in antenatal, obstetric, and neonatal care may prevent some cases of dyskinetic CP @NTNUikom

Professor Marit Otterlei ved @NTNUikom har laget en helt ny type kreftmedisin. Ingen lignende medisiner har kommet så langt i utviklingen på verdensbasis.